ADRIAMYCIN ANALOGS - RATIONALE, SYNTHESIS, AND PRELIMINARY ANTITUMOR EVALUATION OF HIGHLY-ACTIVE DNA-NONBINDING N-(TRIFLUOROACETYL)ADRIAMYCIN 14-O-HEMIESTER DERIVATIVES

被引：36

作者：

ISRAEL, M

POTTI, PG

SESHADRI, R

机构：

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1985年 / 28卷 / 09期

关键词：

D O I：

10.1021/jm00147a017

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1223 / 1228

页数：6

共 46 条

[1]

ABRUZZI R, 1980, CANCER TREAT REP, V64, P873

[2]

ARCAMONE F, 1982, DOXORUBICIN, P103

[3]

Blum R., 1981, NEW DRUGS CANCER CHE, P7

[4] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[5]

BLUM RH, 1979, CANCER TREAT REP, V63, P919

[6] N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE AND ADRIAMYCIN INDUCED DNA DAMAGE IN THE RPMI-6410 HUMAN-LYMPHOBLASTOID CELL-LINE [J].

BROX, L ;

GOWANS, B ;

BELCH, A .

CANADIAN JOURNAL OF BIOCHEMISTRY, 1980, 58 (09) :720-725

[7]

CHABNER BA, 1982, CANCER PRINCIPLES PR, P180

[8] INHIBITION OF CHICKEN MYELOBLASTOSIS RNA POLYMERASE-II ACTIVITY INVITRO BY N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE [J].

CHUANG, LF ;

KAWAHATA, RT ;

CHUANG, RY .

FEBS LETTERS, 1980, 117 (01) :247-251

[9]

CHUANG RY, 1983, J BIOL CHEM, V258, P1062

[10]

DANTCHEV D, 1979, CANCER TREAT REP, V63, P875

← 1 2 3 4 5 →